Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

The Goldman Sachs Group, Inc. 
28.02.23 50%
buy
ViewRay Inc

Start price
Target price
Perf. (%)
€4.14
28.02.23
€7.52
28.02.24
-98.76%
29.02.24

Oppenheimer Holdings Inc. 
28.02.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€133.16
28.02.23
-
28.02.24
-12.89%
29.02.24

StockNews.com 
28.02.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.95
28.02.23
-
28.02.24
41.64%
29.02.24

StockNews.com 
28.02.23 50%
buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€100.00
28.02.23
-
28.02.24
-16.50%
29.02.24

StockNews.com 
28.02.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
28.02.23
-
28.02.24
-
29.02.24

StockNews.com 
28.02.23 50%
buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€83.95
28.02.23
-
28.02.24
13.04%
31.01.24

Saftman 
28.02.23 50%
buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€34.65
27.02.23
-
27.02.24
-13.48%
28.02.24

Societe Generale 
27.02.23 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.18
27.02.23
€1.10
27.02.24
-16.47%
26.04.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
27.02.23 60%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.33
27.02.23
€0.50
27.02.24
-10.72%
02.03.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
27.02.23 50%
buy
Omnicell Inc.

Start price
Target price
Perf. (%)
€50.50
27.02.23
€64.25
27.02.24
-52.48%
28.02.24

Benchmark Co. 
27.02.23 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.97
27.02.23
€15.12
27.02.24
-63.50%
28.02.24

Wedbush 
27.02.23 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€33.00
27.02.23
-
27.02.24
18.79%
28.02.24

The Goldman Sachs Group, Inc. 
27.02.23 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
27.02.23
-
27.02.24
-
28.02.24

StockNews.com 
27.02.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
27.02.23
-
27.02.24
-
28.02.24

StockNews.com 
27.02.23 50%
sell
Avinger Inc.

Start price
Target price
Perf. (%)
€1.00
27.02.23
-
27.02.24
-66.20%
28.02.24

StockNews.com 
27.02.23 50%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€2.64
27.02.23
-
27.02.24
-78.41%
28.02.24

StockNews.com 
27.02.23 50%
sell
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€44.20
26.02.23
-
26.02.24
85.52%
03.03.23

Risky Investment
Global_Player 
26.02.23 50%
buy
Iridex Corp.

Start price
Target price
Perf. (%)
€6.10
26.02.23
-
26.02.24
-
27.02.24

StockNews.com 
26.02.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€8.40
26.02.23
-
26.02.24
-35.12%
27.02.24

StockNews.com 
26.02.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
26.02.23
-
26.02.24
-35.75%
27.02.24

StockNews.com 
26.02.23 50%
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

StockNews.com 
26.02.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.99
26.02.23
-
26.02.24
-56.95%
27.02.24

StockNews.com 
26.02.23 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€31.20
26.02.23
-
26.02.24
-21.79%
27.02.24

SVB Leerink LLC 
26.02.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.02.23
-
26.02.24
-
27.02.24

StockNews.com 
26.02.23 50%